From The Hindu, July 22, 1925: British doctors and press articles
The British press describes this decision as a notable landmark in the progress of doctors, denoting their emancipation from the old-time exclusion and aloofness.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Trump tariff pressure: AstraZeneca to move production to US, announces $50 billion manufacturing push
British pharmaceutical giant AstraZeneca on Tuesday announced plans to invest $50 billion in the United States, including the construction of a multi-billion-dollar manufacturing facility in Virginia—its largest-ever single manufacturing investment—amid rising pressure from the Trump administration's tariff push. Tired of too many ads? go ad free now The company said it expects 50% of its total revenue to come from the US by 2030, underlining its strategic shift toward the American market, AFP reported. 'Today's announcement underpins our belief in America's innovation in biopharmaceuticals,' AstraZeneca CEO Pascal Soriot said in a statement. The announcement comes as US President Donald Trump ramps up threats of new tariffs on pharmaceutical imports, which had long been exempt from his broader import levies. A White House-ordered investigation is currently underway, with duties potentially reaching as high as 200%, according to administration signals. 'For decades Americans have been reliant on foreign supply of key pharmaceutical products,' US Commerce Secretary Howard Lutnick said, AFP quoted. He added that the new tariff measures are aimed at 'ending this structural weakness' in domestic drug supply chains. The Virginia factory forms the centrepiece of AstraZeneca's expanded US operations and reflects broader trends in the industry. Other major pharmaceutical firms, many of which had avoided tariffs for the past 30 years, have also begun shifting investment and production to the US in recent months. AstraZeneca had already announced in April that it was relocating part of its European production to the US, even before the latest tariff measures gained momentum.
Time of India
7 hours ago
- Time of India
AstraZeneca to invest $50 bn in the US amid Trump tariffs
British pharmaceutical giant AstraZeneca on Tuesday said it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington . A large chunk of the funds will go toward building a multi-billion dollar manufacturing centre in Virginia , the company said in a statement, adding that it expects 50 percent of its revenue to come from the United States by 2030. Explore courses from Top Institutes in Please select course: Select a Course Category Others Cybersecurity Degree Project Management healthcare Technology Design Thinking Leadership Finance others Public Policy PGDM Digital Marketing MBA Artificial Intelligence Data Analytics Management Healthcare Product Management Operations Management Data Science Data Science CXO Skills you'll gain: Duration: 9 months IIM Lucknow SEPO - IIML CHRO India Starts on undefined Get Details Skills you'll gain: Duration: 16 Weeks Indian School of Business CERT-ISB Transforming HR with Analytics & AI India Starts on undefined Get Details Skills you'll gain: Duration: 28 Weeks MICA CERT-MICA SBMPR Async India Starts on undefined Get Details Skills you'll gain: Duration: 9 months IIM Lucknow SEPO - IIML CHRO India Starts on undefined Get Details Skills you'll gain: Duration: 28 Weeks MICA CERT-MICA SBMPR Async India Starts on undefined Get Details Skills you'll gain: Duration: 7 Months S P Jain Institute of Management and Research CERT-SPJIMR Exec Cert Prog in AI for Biz India Starts on undefined Get Details "Today's announcement underpins our belief in America's innovation in biopharmaceuticals ," the statement quoted CEO Pascal Soriot as saying.
The Hindu
17 hours ago
- The Hindu
From The Hindu, July 22, 1925: British doctors and press articles
According to the London correspondent of 'The Statesman' the British Medical Association has decided to lift the ban that has hitherto forbidden doctors to contribute articles to the newspapers under their own names. The British press describes this decision as a notable landmark in the progress of doctors, denoting their emancipation from the old-time exclusion and aloofness.
